Thane, India

Atul Daroi

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Atul Daroi of Thane, India

Introduction: Atul Daroi is an innovative inventor based in Thane, India, known for his significant contributions to the pharmaceutical industry. With a strong focus on the development of novel pharmaceutical compositions, Atul has made strides that aim to enhance medical treatments and offer new solutions in healthcare.

Latest Patents: Atul holds a patent for a pharmaceutical composition that consists of ((((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)oxy)methyl pivalate or a pharmaceutically acceptable derivative thereof. This invention also explores the inclusion of additional agents, detailing methods of making these compositions, and defining their applications in medicine. This patent showcases Atul's dedication to advancing therapeutic options for various medical conditions.

Career Highlights: Atul has established himself in the pharmaceutical field through his work at Cipla Limited, a prestigious name in the industry. His role at the company enables him to collaborate with other experts and contribute to significant research and development projects, thus shaping the future of pharmaceuticals.

Collaborations: Working alongside Geena Malhotra, Atul demonstrates the importance of teamwork in innovation. Their collaboration within Cipla Limited enhances the potential for breakthroughs in medication development, underlining the role of creative partnerships in driving pharmaceutical advancements.

Conclusion: Atul Daroi exemplifies the spirit of innovation in the pharmaceutical sector. His unique patent not only represents a technical achievement but also reflects a commitment to improving healthcare outcomes. As he continues his work at Cipla Limited, the future looks promising, both for him and the patients who may benefit from his contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…